Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
| ▸ | BRD2 | P25440 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2032853 | 0.82 | MAPK1 (0.35) | MAPK1PIK3CDBRD4BRD2 | |
| SCHEMBL9251987 | 0.79 | MAPK1 (0.37) | MAPK1PIK3CDBRD4BRD2 | |
| SCHEMBL18883353 | 0.79 | MAPK1 (0.37) | MAPK1PIK3CDBRD4BRD2 | |
| SCHEMBL18821187 | 0.79 | MAPK1 (0.37) | MAPK1PIK3CDBRD4BRD2 | |
| SCHEMBL23108901 | 0.76 | MAPK1 (0.34) | MAPK1PIK3CDBRD4BRD2 | |
| SCHEMBL23480323 | 0.76 | ACE (0.35) | MAPK1BRD4 | |
| SCHEMBL17572147 | 0.71 | — | — | |
| SCHEMBL9825169 | 0.71 | — | — | |
| SCHEMBL146924 | 0.69 | — | — | |
| SCHEMBL23631117 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10479819-B2 | Oxyntomodulin analogue | JIANG, Xianxing (CN) | 2019-11-19 | — | — | US | disclosed |
| US-20190002444-A1 | CRYSTALLINE FORMS OF VILAZODONE HYDROCHLORIDE AND VILAZODONE FREE BASE | DR. REDDY'S LABORATORIES LIMITED (IN) | 2019-01-03 | — | — | US | disclosed |
| US-10011590-B2 | Crystalline forms of vilazodone hydrochloride and vilazodone free base | DR. REDDY'S LABORATORIES LIMITED (IN) | 2018-07-03 | — | — | US | disclosed |
| US-20170217939-A1 | CRYSTALLINE FORMS OF VILAZODONE HYDROCHLORIDE AND VILAZODONE FREE BASE | DR. REDDY'S LABORATORIES LIMITED (IN) | 2017-08-03 | — | — | US | disclosed |
| US-20170183383-A1 | OXYNTOMODULIN ANALOGUE | SHENZHEN TURIER BIOTECH CO., LTD. (CN) | 2017-06-29 | — | — | US | disclosed |
| US-20150126525-A1 | CRYSTALLINE FORMS OF VILAZODONE HYDROCHLORIDE AND VILAZODONE FREE BASE | REDDYS LAB LTD DR (IN) | 2015-05-07 | — | — | US | disclosed |
| WO-2013168126-A1 | CRYSTALLINE FORMS OF VILAZODONE HYDROCHLORIDE AND VILAZODONE FREE BASE | DR.REDDYS LABORATORIES LIMITED (IN) | 2013-11-14 | — | — | WO | disclosed |
| US-4113680-A | Method for preparing 17 α-ester-21-halo pregnanes | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1978-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150126525-A1 | CRYSTALLINE FORMS OF VILAZODONE HYDROCHLORIDE AND VILAZODONE FREE BASE | VIL1, VMA21, PYGL | MAPK1 3270/4885PIK3CD 2917/4885BRD4 3732/4885 |
| US-20170217939-A1 | CRYSTALLINE FORMS OF VILAZODONE HYDROCHLORIDE AND VILAZODONE FREE BASE | VIL1, VMA21, PYGL | MAPK1 3704/4885PIK3CD 3526/4885BRD4 4304/4885 |
| US-20170183383-A1 | OXYNTOMODULIN ANALOGUE | GCGR, GLP1R, GIPR | MAPK1 1834/4885PIK3CD 3614/4885BRD4 4278/4885 |
| US-10011590-B2 | Crystalline forms of vilazodone hydrochloride and vilazodone free base | VIL1, VMA21, PYGL | MAPK1 3704/4885PIK3CD 3526/4885BRD4 4304/4885 |
| US-10479819-B2 | Oxyntomodulin analogue | GCGR, GLP1R, GIPR | MAPK1 1834/4885PIK3CD 3614/4885BRD4 4278/4885 |
| US-20190002444-A1 | CRYSTALLINE FORMS OF VILAZODONE HYDROCHLORIDE AND VILAZODONE FREE BASE | VIL1, VMA21, PYGL | MAPK1 3704/4885PIK3CD 3526/4885BRD4 4304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.